The largest database of trusted experimental protocols

Tk renilla luciferase plasmid

Manufactured by Promega
Sourced in United States

The TK-Renilla luciferase plasmid is a genetic construct that contains the Renilla luciferase gene under the control of the Herpes Simplex Virus Thymidine Kinase (HSV-TK) promoter. The Renilla luciferase enzyme catalyzes the oxidation of the substrate coelenterazine, resulting in the emission of light. This plasmid can be used to monitor gene expression or reporter activity in various cell-based assays.

Automatically generated - may contain errors

6 protocols using tk renilla luciferase plasmid

1

Hedgehog Pathway Modulation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The TCF/LEF luciferase reporter plasmid, NF-κB luciferase reporter plasmid, and TK-Renilla luciferase plasmid were purchased from Promega (Madison, WI, USA). Smo plasmid was purchased from Origene (Rockville, MD, USA). The Smo mutant plasmids were generated from wild type Smo plasmid using QuickChange Site-Directed Mutagenesis kit from Agilent (Santa Clara, CA, USA) and confirmed by sequencing. Information on Smo mutants plasmids is provided in Supplementary data 2. The Gli1 plasmid and Gli2-HA plasmid were obtained from Addgene (Cambridge, MA, USA). Transient transfections were performed by Lipofectamine 2000 reagent from Invitrogen (Grand Island, NY, USA) according to the manufacturer's instructions.
+ Open protocol
+ Expand
2

Dual Luciferase Reporter Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were routinely cotransfected with a TK-Renilla luciferase plasmid (Promega, Madison, WI, USA) to normalize for the transfection efficacy. The Dual Luciferase Reporter Assay Kit from Promega was used following the manufacturer's protocol. Luciferase activity was measured with a Victor X3 2030 multi-label plate reader (PerkinElmer, Eden Prairie, MN, USA). The data are represented the mean values obtained from three independent experiments.
+ Open protocol
+ Expand
3

Lentiviral-Mediated Knockdown of Sufu in NIH-3T3 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The 8 × Gli1-binding site luciferase reporter (8 × GBS-luciferase) plasmid was a kind gift from Dr. Hiroshi Sasaki. The TCF/LEF-luciferase reporter plasmid, NF-κB –luciferase reporter plasmid, and TK-Renilla luciferase plasmid were purchased from Promega (Madison, WI). The Gli2 lacking the N-termianl (Gli2ΔN) plasmid and ShhN plasmids were obtained from Addgene (Cambridge, MA). The Myc-DKK-tagged ORF clone of Homo sapiens Smo plasmid was purchased from Origene (Rockville, MD). The mutant human plasmid SmoM2 (W535L) was generated from wild type Smo plasmids using QuickChange Site-Directed Mutagenesis kit from Agilent (Santa Clara, CA) and was confirmed by sequencing. The Sufu-shRNA was purchased from Santa Cruz (Santa Cruz, CA).
Transient transfections were performed using Lipofectamine 2000 reagent from Invitrogen according to the manufacturer’s instructions. The lentiviral stocks were prepared according to previous report [19 (link)]. Briefly, the plasmid carrying the Sufu-shRNA and three packaging plasmids were co-transfected into 293T cells using Lipofectamine 2000. The viruses were harvested 24 h post transfection and 4 ml viruses were used for infected NIH-3T3 cells seeded in 10-cm dishes. Infected cells were analyzed 5–7 days post infection by western blot analyses of the expression of Sufu.
+ Open protocol
+ Expand
4

Luciferase Reporter Assay in HEK293 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were routinely co-transfected with a TK-Renilla luciferase plasmid (Promega, Madison, WI, USA) to normalize for the transfection efficacy. To determine luciferase expression, the pGL4.38 [luc2P/p53 RE/Hygro] Vector (Promega) was transfected into HEK293 cells 1 day after plating. The indicated treatments were performed 24 h after transfection, and the cells were collected according to the manufacturer's instructions (Roche Diagnostics, Roswell, GA, USA). Briefly, the cell lysates were prepared with 1 × lysis buffer, and the luciferase reporter signals were detected immediately after adding luciferin substrates using a Fluoroskan Ascent FL System (Thermo Scientific, Waltham, MA, USA). The data shown represent the mean values obtained from three independent experiments.
+ Open protocol
+ Expand
5

HEV Genotype 3 Kernow P6 Virus Propagation

Check if the same lab product or an alternative is used in the 5 most similar protocols
293T cells, Huh7-S10-3 liver cells, and IPEC-J2 intestinal epithelial cells were maintained in Dulbecco’s modified Eagle medium (DMEM) containing 10% fetal calf serum (FCS), 1× antibacterial-antimycotic, and 1× minimal essential amino acid (Gibco-Thermo Fisher, MA, USA). The HEV genotype 3 Kernow P6 virus stock was prepared by transfecting Huh7-S10-3 cells with in vitro-transcribed capped RNA transcripts from the HEV Kernow P6 infectious clone. The following antibodies and siRNA were used in this study: anti-IRF3 (1:1,000; SCBT, CA, USA), anti-phospho-IRF3 (1:1,000; Millipore, MA, USA), anti-glyceraldehyde-3-phosphate dehydrogenase-horseradish peroxidase (anti-GAPDH-HRP) (1:5,000; Invitrogen, MA, USA), bovine-anti-rabbit-HRP (1:7,000; SCBT, CA, USA), donkey-anti-rabbit-rhodamine red Fab (1:2,000; Jackson Laboratory, ME, USA), and siRIG-I (20 μM; SCBT, CA, USA). The IFN-β-firefly luciferase plasmid and TK-Renilla luciferase plasmid for the IFN promoter assay were purchased from Promega (WI, USA). The pLIX-402 lentiviral vector and second-generation lentiviral packing vectors (psPAX2 and pMD2.G) were procured from Addgene (MA, USA).
+ Open protocol
+ Expand
6

Evaluating BCL6 BTB Domain Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
The reporter construct (GAL4) 5 -TK-LUC and the GAL4-DBD-BCL6 BTB expression plasmid were kindly provided by Dr. Ari Melnick (Weill Cornell Medical College, Department of Haematology/Oncology, New York, NY, USA.) A TK-Renilla luciferase plasmid was included as an internal control (Promega, WA, USA).
293T cells were cotransfected with (GAL4) 5 -TK-LUC and GAL4-DBD-BCL6 BTB or GAL4-DBD plus a TK-Renilla reporter construct using Lipofectamine 2000 (Thermo Fisher Scienti c). After transfection for 6 h, the cells were treated with the compounds for 24 h. A dual luciferase assay was performed according to the manufacturer's guidelines (Promega, WA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!